{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:42:30Z","timestamp":1769830950196,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"DOI":"10.7759\/cureus.102635","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:42:44Z","timestamp":1769784164000},"source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab-Associated Ocular Surface Disease in a Local Asian Chinese Population"],"prefix":"10.7759","author":[{"given":"Anita  L","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea C","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian W","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C","family":"Luk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai Wang Kenneth","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2023.02.003","article-title":"Diagnosing atopic dermatitis in skin of color","volume":"41","author":"Adawi W","year":"2023","unstructured":"Adawi W, Cornman H, Kambala A, Henry S, Kwatra SG. Diagnosing atopic dermatitis in skin of color. Dermatol Clin. 2023, 41:417-29. 10.1016\/j.det.2023.02.003","journal-title":"Dermatol Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.1241","article-title":"A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis","volume":"80","author":"Lee HH","year":"2019","unstructured":"Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019, 80:1526-32.e7. 10.1016\/j.jaad.2018.05.1241","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo JA","year":"2009","unstructured":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009, 124:1251-8.e23. 10.1016\/j.jaci.2009.10.009","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000001102","article-title":"Emerging concepts in atopic dermatitis and atopic keratoconjunctivitis","volume":"25","author":"Jafari K","year":"2025","unstructured":"Jafari K, Calder VL. Emerging concepts in atopic dermatitis and atopic keratoconjunctivitis. Curr Opin Allergy Clin Immunol. 2025, 25:388-94. 10.1097\/ACI.0000000000001102","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002866","article-title":"Prevalence and characteristics of dupilumab-induced ocular surface disease in adults with atopic dermatitis","volume":"41","author":"Felfeli T","year":"2022","unstructured":"Felfeli T, Georgakopoulos JR, Jo CE, et al.. Prevalence and characteristics of dupilumab-induced ocular surface disease in adults with atopic dermatitis. Cornea. 2022, 41:1242-7. 10.1097\/ICO.0000000000002866","journal-title":"Cornea"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","year":"1993","unstructured":"Severity scoring of atopic dermatitis. the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993, 186:23-31. 10.1159\/000247298","journal-title":"Dermatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16724","article-title":"Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study","volume":"35","author":"Touhouche AT","year":"2021","unstructured":"Touhouche AT, Cassagne M, B\u00e9rard E, et al.. Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study. J Eur Acad Dermatol Venereol. 2021, 35:172-9. 10.1111\/jdv.16724","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.1128","article-title":"Identification of risk factors for dupilumab-associated ocular surface disease in patients with atopic dermatitis","volume":"102","author":"Achten RE","year":"2022","unstructured":"Achten RE, Van Luijk C, Van der Rijst L, et al.. Identification of risk factors for dupilumab-associated ocular surface disease in patients with atopic dermatitis. Acta Derm Venereol. 2022, 102:adv00666. 10.2340\/actadv.v102.1128","journal-title":"Acta Derm Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1425550","article-title":"A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis","volume":"15","author":"Shim S","year":"2024","unstructured":"Shim S, Kim JS, Yee J, Gwak HS. A risk-scoring system to predict dupilumab-associated ocular surface disease in patients with atopic dermatitis. Front Pharmacol. 2024, 15:1425550. 10.3389\/fphar.2024.1425550","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15814","article-title":"Dupilumab-associated ocular surface disease in pediatric atopic dermatitis: a single-center Asian experience","volume":"42","author":"Yap AX","year":"2025","unstructured":"Yap AX, Tan D, Koh MJ, Yang LY, Zhe KY, Wee LW. Dupilumab-associated ocular surface disease in pediatric atopic dermatitis: a single-center Asian experience. Pediatr Dermatol. 2025, 42:481-6. 10.1111\/pde.15814","journal-title":"Pediatr Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae344","article-title":"An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024","volume":"191","author":"Ardern-Jones MR","year":"2024","unstructured":"Ardern-Jones MR, Brown SJ, Flohr C, et al.. An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024. Br J Dermatol. 2024, 191:865-85. 10.1093\/bjd\/ljae344","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456036-dupilumab-associated-ocular-surface-disease-in-a-local-asian-chinese-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:42:44Z","timestamp":1769784164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456036-dupilumab-associated-ocular-surface-disease-in-a-local-asian-chinese-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.102635","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}